Patents by Inventor Eric Thomas Fung
Eric Thomas Fung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11926138Abstract: Fibrous structures, for example sanitary tissue products, such as toilet tissue, and more particularly fibrous structures containing a movable surface and methods for making same and methods for making same are provided.Type: GrantFiled: November 17, 2021Date of Patent: March 12, 2024Assignee: The Procter & Gamble CompanyInventors: Joerg Kleinwaechter, Eric Bryan Bond, Matthew Gary McKee, Hasan Eroglu, Tyler Jacob Werner, Jeffrey Chan, Joshua Thomas Fung, Jeffrey Glen Sheehan, Paul Dennis Trokhan, Jean A. Ibrahim
-
Publication number: 20210181207Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.Type: ApplicationFiled: December 14, 2020Publication date: June 17, 2021Applicants: ASPIRA WOMEN'S HEALTH INC., THE JOHNS HOPKINS UNIVERSITYInventors: ERIC THOMAS FUNG, ENRIQUE DALMASSO, VLADIMIR PODUST, ZHENG WANG, Zhen Zhang
-
Publication number: 20170089906Abstract: The present invention provides protein-based biomarkers and biomarker combinations that am useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.Type: ApplicationFiled: November 30, 2016Publication date: March 30, 2017Applicants: VERMILLION, INC., THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATIONInventors: ERIC THOMAS FUNG, FREDERICK RAND UELAND, J.R. VAN NAGELL, PAUL DUANE DEPRIEST, ANDRE THOMAS BARON
-
Publication number: 20140038837Abstract: The present invention provides methods and compositions for detecting early stage ovarian cancer in a patient. Also, methods for evaluating the ovarian cancer state of a patient are described herein. These methods involve the detection, analysis, and classification of biomarkers in biological samples.Type: ApplicationFiled: June 3, 2013Publication date: February 6, 2014Applicants: Board of Regents, The University of Texas System, Vermillion, Inc.Inventors: Eric Thomas Fung, Charlotte Clarke, Robert Bast, Kevin Coombes
-
Publication number: 20140038899Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.Type: ApplicationFiled: June 12, 2013Publication date: February 6, 2014Applicants: The University of Kentucky Research Foundation, Vermillion, Inc.Inventors: Eric Thomas Fung, Frederick Rand Ueland, Van Nagell, JR., Paul Duane Depriest, Andre Thomas Baron
-
Patent number: 8206934Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry, immunoassay, or other means.Type: GrantFiled: September 11, 2009Date of Patent: June 26, 2012Assignee: Vermillion, Inc.Inventors: Eric Thomas Fung, Tai-Tung Yip, Vladimir Podust, Mats Brannstrom, Karin Sundfeldt, Bjorg Kristjansdottir
-
Publication number: 20100197561Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.Type: ApplicationFiled: June 23, 2006Publication date: August 5, 2010Applicant: Ciphergen Biosystems, Inc.Inventors: Eric Thomas Fung, Enrique Dalmasso, Valdimir Podust, Zheng Wang
-
Publication number: 20100173788Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying breast cancer status in a patient. In particular, the biomarkers of this invention are useful to determine metastasis-free survival of breast cancer patients. The biomarkers can be detected by SELDI mass spectrometry in serum samples fractionated by means of anion exchange chromatography. Some of the biomarkers have been identified as: Apolipoprotein A1; Apolipoprotein A2; Haptoglobin alpha 1; Transferrin; Complement C3a; and truncated forms thereof.Type: ApplicationFiled: June 20, 2006Publication date: July 8, 2010Inventors: Anthony Goncalves, Jean-Paul Borg, Eric Thomas Fung, Xiao-Ying Meng
-
Publication number: 20100105067Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry.Type: ApplicationFiled: June 23, 2006Publication date: April 29, 2010Applicants: CIPHERGEN BIOSYSTMES, INC., UNIVERSITY OF KENTUCKY RESEARCH FOUNDATIONInventors: Eric Thomas Fung, Frederick Rand Ueland, J.R. van Nagell, Paul Duane Depriest, Andre Thomas Baron
-
Publication number: 20080160540Abstract: The present invention relates to the identification and use of polypeptides that bind to antibodies directed to a desired polypeptide of interest. Using natriuretic peptides and their precursors, and in particular BNP, as an example, the present invention describes a number of natriuretic peptides fragments produced in biological samples, most preferably blood-derived samples, that bind to antibodies directed to BNP. Because production of such fragments is an ongoing process that may be a function of, inter alia, the elapsed time between onset of an event triggering natriuretic peptide release into the tissues and the time the sample is obtained or analyzed; the elapsed time between sample acquisition and the time the sample is analyzed; the type of tissue sample at issue; the storage conditions; the quantity of proteolytic enzymes present; etc.Type: ApplicationFiled: January 14, 2008Publication date: July 3, 2008Applicants: BIOSITE INCORPORATED, VERMILLION, INC.Inventors: Kenneth F. Buechler, Eric Thomas Fung, Tai-Tung Yip
-
Patent number: 7341838Abstract: The present invention relates to the identification and use of polypeptides that bind to antibodies directed to a desired polypeptide of interest. Using natriuretic peptides and their precursors, and in particular BNP, as an example, the present invention describes a number of natriuretic peptides fragments produced in biological samples, most preferably blood-derived samples, that bind to antibodies directed to BNP. Because production of such fragments is an ongoing process that may be a function of, inter alia, the elapsed time between onset of an event triggering natriuretic peptide release into the tissues and the time the sample is obtained or analyzed; the elapsed time between sample acquisition and the time the sample is analyzed; the type of tissue sample at issue; the storage conditions; the quantity of proteolytic enzymes present; etc.Type: GrantFiled: April 19, 2004Date of Patent: March 11, 2008Assignees: Biosite Incorporated, Vermillion, Inc.Inventors: Kenneth F. Buechler, Eric Thomas Fung, Tai-Tung Yip